Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Robert D. Hilgers"'
Publikováno v:
Journal of Surgical Oncology. 75:60-71
Publikováno v:
Gynecologic Oncology. 60:450-453
Background: To determine the effect of granulocyte colony-stimulating factor (G-CSF) on tumor growth and cisplatin cytotoxicity in human epithelial ovarian cancer. Methods: Six human epithelial ovarian cancer cell lines were treated with media (contr
Autor:
Robert D. Hilgers, Roland D. Cull, Michael R. Baker, James Fanning, Robert C. Burke, Charles E. Neal, Jan Snodgrass
Publikováno v:
Clinical Nuclear Medicine. 18:472-476
Fifteen presurgical patients with a history of ovarian carcinoma were evaluated with immunoscintigraphy using the In-111-labeled monoclonal antibody conjugate CYT-103. Twelve of these patients had residual neoplasia at time of laparotomy. A single in
Publikováno v:
Gynecologic Oncology. 41:117-122
Seventeen patients with low- or medium-risk gestational trophoblastic tumors (GTT) and one patient with a placental-site trophoblastic tumor were treated according to an 8-day schedule of low-dose methotrexate (LDMTX) alternating with citrovorum fact
Autor:
Robert D, Hilgers, Stephen W, Wyatt
Publikováno v:
The Journal of the Kentucky Medical Association. 105(5)
Autor:
Robert D, Hilgers, Stephen W, Wyatt
Publikováno v:
The Journal of the Kentucky Medical Association. 105(5)
Autor:
Robert D, Hilgers
Publikováno v:
The Journal of the Kentucky Medical Association. 105(5)
Autor:
Harriet O, Smith, Clifford R, Qualls, Robert D, Hilgers, Claire F, Verschraegen, William F, Rayburn, Laurence W, Cole, Luis A, Padilla, Charles R, Key
Publikováno v:
The Journal of reproductive medicine. 49(7)
To analyze gestational trophoblastic neoplasia (GTN) trends among American Indians (AI) using population-based data.GTN incidence, by race and age, was calculated using data collected by the New Mexico Tumor Registry over 29 years (1973-2001). Live b
Publikováno v:
Gynecologic Oncology. 59:191-193
During the course of four recent dose-intense chemotherapy trials, the routine practice of transfusing patients with platelet counts20,000/microliters was changed to a more conservative style of management limiting prophylactic transfusions to patien
Publikováno v:
American Journal of Clinical Oncology. 17:335-337
A total of 25 patients with epithelial ovarian cancer were treated with second-line carboplatin, etoposide, and ifosfamide (ICE) following failure of first-line cisplatin-based combination chemotherapy. The combination carboplatin 35 mg/m2, etoposide